Effect of Intravenous Infusion of Lidocaine or Magnesium on Postoperative Recovery Quality in Patients Undergoing Endoscopic Surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900021986

Enrollment

Unknown

Registered

2019-03-19

Start date

2019-03-19

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopic surgery

Interventions

Group 1:lidocaine

Group 2:magnesium sulphate

Grup 3:Saline

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Scheduled to undergo laparoscopic surgery under general anesthesia; 2. Aged 20~65 years; 3. BMI18.5~28 kg/m2; 4. Agree to participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Experiencing pain before surgery for any reason and take analgesics; 2. Pregnancy or breast feeding; 3. Signifcant heart, kidney, or liver disease; 4. Psychiatric or neurological disorders; 5. Contraindications or hypersensitivity reactions to lidocaine or magnesium.

Design outcomes

Primary

Measure	Time frame
Quality of recovery;	—

Secondary

Measure	Time frame
Heart rate;Spo2;Blood pressure;NRS pain scale;Nausea and vomiting;Sedation score;	—

Countries

China

Contacts

Public ContactWei Cheng

53974314@qq.com+86 18052268817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026